Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 2, 2025 - Amgen launched Bkemv (eculizumab-aeeb), biosimilar and interchangeable to AstraZeneca’s Soliris (eculizumab).
Download PDF
Return to publications
